GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $203,000 | -46.0% | 2,083 | -32.0% | 0.00% | – |
| Q2 2020 | $376,000 | +60.0% | 3,064 | +14.4% | 0.00% | – |
| Q1 2020 | $235,000 | +15.8% | 2,679 | +37.8% | 0.00% | – |
| Q4 2019 | $203,000 | -6.0% | 1,944 | +3.7% | 0.00% | – |
| Q3 2019 | $216,000 | -37.8% | 1,875 | -6.9% | 0.00% | – |
| Q2 2019 | $347,000 | +7.1% | 2,014 | +4.8% | 0.00% | – |
| Q1 2019 | $324,000 | -28.0% | 1,922 | -58.4% | 0.00% | -100.0% |
| Q4 2018 | $450,000 | +278.2% | 4,623 | +439.4% | 0.00% | – |
| Q2 2018 | $119,000 | +1883.3% | 857 | +1847.7% | 0.00% | – |
| Q4 2017 | $6,000 | -88.5% | 44 | -91.4% | 0.00% | – |
| Q3 2017 | $52,000 | -46.4% | 511 | -46.9% | 0.00% | – |
| Q2 2017 | $97,000 | -41.6% | 963 | -30.1% | 0.00% | -100.0% |
| Q1 2017 | $166,000 | +7.8% | 1,378 | +0.1% | 0.00% | 0.0% |
| Q4 2016 | $154,000 | +4.1% | 1,376 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $148,000 | – | 1,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |